HF
CLB icon

HRT Financial’s Core Laboratories CLB Stock Holding History

HRT Financial’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-126,056
Closed -$2.02M – 3900
2025
Q4 		$2.02M Sell
126,056
-223,490
-64% -$3.33M 0.01% 1298
2025
Q3 		$4.32M Buy
349,546
+259,141
+287% +$3.04M 0.02% 739
2025
Q2 		$1.04M Buy
+90,405
New +$1.07M ﹤0.01% 1250
2024
Q4 		– Sell
-17,784
Closed -$329K – 2518
2024
Q3 		$329K Buy
+17,784
New +$357K ﹤0.01% 1770
2023
Q2 		– Sell
-9,890
Closed -$218K – 2564
2023
Q1 		$218K Buy
+9,890
New +$231K ﹤0.01% 1887
2021
Q2 		– Sell
-14,734
Closed -$424K – 2927
2021
Q1 		$424K Buy
+14,734
New +$503K ﹤0.01% 1911
2020
Q4 		– Sell
-168,772
Closed -$2.58M – 1919
2020
Q3 		$2.58M Sell
168,772
-413,221
-71% -$8.66M 0.07% 179
2020
Q2 		$11.8M Buy
+581,993
New +$10.4M 0.36% 53

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HRT Financial's CLB Position: Q1 2026 in Review

HRT Financial sold out of Core Laboratories (CLB) in Q1 2026, closing a stake of 126,056 shares — an estimated $2.02M sold.

HRT Financial first reported a position in CLB in Q2 2020 and held it in 8 quarters. The position peaked at $11.8M in Q2 2020. 190 funds tracked by Wall St. Rank hold CLB as of Q1 2026.

  • HRT Financial reported no remaining Core Laboratories position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 126,056 Core Laboratories shares in Q1 2026, an estimated $2.02M.
  • HRT Financial first reported a position in Core Laboratories in Q2 2020 and held it in 8 quarters.
  • HRT Financial's Core Laboratories position peaked at $11.8M in Q2 2020.
  • 190 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.